EGFR and neoplasm: A large number of basic medical studies, clinical applications, and studies for many years have shown that PA-MSHA injection can induce the activation of dendritic cells, activate the adaptive immune response, activate macrophages, improve tumor microenvironment, specifically adhere to tumor cells, block EGFR signal pathway and induce tumor cell apoptosis.